AI-generated analysis. Always verify with the original filing.
60 Degrees Pharmaceuticals, Inc. disclosed on March 20, 2026, a correction to an error in its Prospectus Supplement dated March 13, 2026, stating an affiliate beneficially owns 23,367 shares of common stock instead of 21,490 shares (16,781 shares post 1-for-4 reverse stock split instead of 15,905 shares). The error originated from a Form 4 filed September 15, 2025, and no other information in the Prospectus Supplement is affected.